Ann: FY 2017 Results Presentation, page-5

Yes, ebitda and revenue for Imaging like for like stronger than headlines numbers due to closure of non performing sites and $12m costs in sale and leaseback changes; underlying profit strong for that division.

Overall, business clearly now generating strong free cashflow, legacy of old model being put behind it, doctor numbers growing at good rate. Income growth will come through for med Centres as higher doctor numbers feed into system.

Pathology revenue growth strong, rental costs impacting profits and to be worked in fy 19.

As previous said, the old model made accounting profits look good while debt was raised to fund dividends.

Some $400m debt repaid in 2 years.